Features

Israel-based Kanabo Research is one of many emerging firms leading the international surge of research and development into the potential of...

In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores the history of...

Pharmafocus spoke to head figures from three of the Alliance’s founding partners to get a feel for how it will operate, how it will deliver on...

Patrick Connor, VP and Global Franchise Head, Tumor Drivers and Resistance Mechanisms, at AstraZeneca, discusses his company’s role in the Lung...

On 24 September, the United Nations convened in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s Global Head of Pharma...

Steve Rothberg was blindsided by an AML diagnosis that progressed rapidly with little warning. Ten years later, he discusses his outlook and...

Patrick Connor, VP and Global Franchise Head, Tumor Drivers and Resistance Mechanisms, at AstraZeneca, discusses his company’s role in the Lung...

FDA activity has fallen under Donald Trump, with the number of warning letters issued by the regulator dropping by a third since the President...

Charlotte Walker-Osborn, Partner and International Technology Sector Head and Nabil Asaad, Senior Associate, Intellectual Property Law Group –...

“What we believe is objective science and truth at any one moment can be proven to be wrong a few years later”